Preclinical development of metalloproteasis inhibitors in cancer therapy
- 26 January 2001
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 37 (1) , 53-60
- https://doi.org/10.1016/s1040-8428(00)00096-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant ResistancePublished by Elsevier ,1999
- Matrix MetalloproteinasesJournal of Biological Chemistry, 1999
- Regulation of matrix metalloproteinase expression in tumor invasionThe FASEB Journal, 1999
- Matrix metalloproteinases in angiogenesis: a moving target for therapeutic interventionJournal of Clinical Investigation, 1999
- Angiostatin-converting Enzyme Activities of Human Matrilysin (MMP-7) and Gelatinase B/Type IV Collagenase (MMP-9)Journal of Biological Chemistry, 1997
- ECM and Cell Surface Proteolysis: Regulating Cellular EcologyCell, 1997
- Changing views of the role of matrix metalloproteinases in metastasisJNCI Journal of the National Cancer Institute, 1997
- Macrophage-Derived Metalloelastase Is Responsible for the Generation of Angiostatin in Lewis Lung CarcinomaCell, 1997
- Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasisCancer and Metastasis Reviews, 1995
- Biology and biochemistry of proteinases in tumor invasionPhysiological Reviews, 1993